| JKN486
|
Research Grade Prolgolimab
|
2093956-19-3 |
95% |
None
|
| JKN485
|
Research Grade Priliximab
|
147191-91-1 |
95% |
None
|
| JKN484
|
Research Grade Prasinezumab
|
1960462-19-4 |
95% |
None
|
| JKN483
|
Research Grade Otilimab
|
1638332-55-4 |
95% |
None
|
| JKN482
|
Research Grade Omburtamab
|
1895083-75-6 |
95% |
None
|
| JKN480
|
Research Grade Obexelimab
|
1690307-05-1 |
95% |
None
|
| JKN479
|
Research Grade Nemolizumab
|
1476039-58-3 |
95% |
None
|
| JKN478
|
Research Grade Muromonab-Cd3
|
140608-64-6 |
95% |
None
|
| JKN477
|
Research Grade Mosunetuzumab
|
1905409-39-3 |
95% |
None
|
| JKN476
|
Research Grade Mitazalimab
|
2055640-86-1 |
95% |
None
|
鄂公网安备42011102005485号
鄂ICP备2024034540号
? 2023万利官网
